Anesthesia & Life Support

Deltex Medical is a global leader in haemodynamic monitoring technology, specializing in oesophageal Doppler monitoring (ODM) systems. The company manufactures the TrueVue™ advanced haemodynamic monitoring platform, designed to provide real-time, precise patient haemodynamic data for use in surgical and critical care settings. The TrueVue™ system features enhanced ODM signal acquisition, intuitive HD touchscreen controls, integrated battery for portability, and user-centric design to support clinicians across varied clinical environments. The technology is clinically proven to help reduce avoidable complications including acute kidney injury, acute respiratory distress syndrome, and surgical site infections. Deltex Medical serves anaesthetists and critical care specialists globally, with manufacturing and regulatory operations based in the United Kingdom. The company offers eLearning and training resources through its dedicated education platform, and maintains customer support through regional enquiry lines and service channels.

Voss Medical Products is a medical device developer and distributor specializing in single-use, disposable surgical products for operating room and procedural applications. The company distributes products under two primary licensing divisions: VM/Positioning and VM/Cardio Vascular. The VM/Positioning line includes specialty positioning devices designed to support patient positioning during prone procedures, spine surgery, cardiovascular vein harvesting, and airway management. Key products include The Prone Positioner™ (introduced 1985, the company's flagship product), The Leg Positioner™ for vein harvesting during coronary bypass, The Voss Supine™ for airway management during intubation, The Notch™ for securing nasal or oral RAE tubes, and laminectomy arm cradles. Recently expanded offerings include foam positioning products for obese patients: Prone XL™, Supine XL™, and Cardiac Leg Support XL™—all disposable, single-use devices. The VM/Cardio Vascular division manufactures devices specifically for coronary bypass procedures, including The Coronary Bypass Marker, The Coronary Bypass Clamp, and The Coronary Bypass Cannula. The company also manufactures The Disposable V-Scope™, a single-use laryngoscope combining precision with cost-effectiveness and disposability. All products are disposable, designed for strength and durability, and positioned as cost-effective alternatives to reusable devices. The Prone Positioner™ is priced 40% below comparable devices and requires no additional hardware. Company offers 100% satisfaction guarantee on all products.

International Medical Development, Inc. (IMD) is a specialized medical device manufacturer focused on innovative spinal needles for anesthesia and diagnostic procedures. The company is best known for the Gertie Marx® needle, a proprietary atraumatic needle design that has been clinically proven to dramatically reduce post-dural puncture headache (PDPH) occurrence from ~30% to less than 1% with proper technique. Founded on this pioneering design over 30 years ago, IMD develops, manufactures, and distributes a comprehensive range of spinal needles to hospitals, surgical centers, and medical institutions globally. The product portfolio includes gauges from 22G to 27G with lengths ranging from 50mm to 215mm, ensuring optimal options for diverse patient populations from pediatric to obese patients. IMD needles are used in obstetric anesthesia, neuraxial anesthesia procedures, lumbar punctures, and intrathecal chemotherapy applications. The company emphasizes clinical outcomes, patient safety, and physician feedback in continuous product refinement.

Medasense Biometrics Ltd. is an Israel-based medtech company specializing in AI-driven nociception monitoring to quantify pain response and optimize analgesia in clinical settings. The company's proprietary NOL® technology analyzes physiological signals to help clinicians personalize pain treatment, reduce opioid use, and prevent postoperative pain. The FDA-authorized PMD-200™ platform is designed for critical care applications including anesthesia and surgery, providing real-time visualization of patient pain levels. Medasense's pipeline includes NOLedge™, which extends pain insights to clinic and home care settings. The company addresses the global pain management crisis through non-invasive quantification of pain responses, supporting healthcare providers with clinical evidence, education via Medasense Academy, and collaborations with major OEMs including Medtronic, Philips, Mindray, and Nihon Kohden. Applications span intraoperative monitoring, postoperative pain prevention, and emergency care settings.

Sensimedical LLC is a specialized manufacturer and distributor of sterile water, saline solutions, and medical consumables across the Americas. Founded in 1991, the company operates manufacturing facilities in Texas and El Salvador, serving 15+ countries with ISO and FDA-compliant products. Operating as a certified minority-owned business (FSMSDC), Sensimedical supplies major U.S. hospital systems, including 20 of the top 50 hospitals, through established GPOs and distributors. The company offers a comprehensive portfolio including sterile water for inhalation and irrigation, saline solutions, respiratory products, anesthesia supplies, wound care items, and infusion consumables. The RSVP (Reserve Supply Value Program) guarantees uninterrupted supply with near-shore production and 90-day exclusive inventory reserves. All products are DEHP-free and meet rigorous international quality standards.

Hemostasis, LLC is a FDA-registered, ISO 13485:2016-certified medical device manufacturer specializing in advanced biomaterial-based hemostasis and wound-healing technologies. The company develops and manufactures innovative bleeding-control products utilizing pharmaceutical-grade NOCC chitosan polymer technology. Core offerings include PosiSep® branded hemostat dressings and intranasal splints for ENT sinus procedures, NexStat® and Accel® topical hemostatic powders, BleedArrest® foam sponges, BoneSeal® bone hemostats, and NexFoam® topical hemostat sponges. Products are designed for diverse surgical applications including sinus, cardiac, orthopedic, vascular, soft tissue, and solid organ procedures. The company provides custom manufacturing services for OEMs and maintains active research and development capabilities in bleeding control technologies.

Global Blood Resources manufactures the Hemobag®, a specialized blood salvage system designed for cardiac surgery. The Hemobag® is a single-use, disposable device that recovers and concentrates all autologous whole blood components—red cells, platelets, clotting factors, and plasma proteins—during cardiopulmonary bypass procedures. Unlike conventional cell salvage methods that discard critical components, the Hemobag® preserves the complete blood profile for rapid re-infusion back to the patient. This reduces the need for allogeneic blood transfusions, lowers post-operative bleeding risk, minimizes transfusion-related complications, and decreases overall transfusion costs. The system is designed for use by perfusionists, cardiac surgeons, and anesthesiologists in the operating room, requiring no additional equipment or extensive training. The standard order includes the Hemobag units paired with TS3 tubing sets.

Cresilon Inc. is a Brooklyn-based biotechnology company specializing in plant-based hemostatic gel medical devices designed to control bleeding rapidly across trauma, surgical, and veterinary applications. Founded in 2010, the company develops flowable hydrogel technology that achieves hemostasis in seconds without manual pressure, addressing critical gaps in hemorrhage control. TRAUMAGEL®, FDA-cleared in 2023, targets emergency medicine, trauma hospitals, military, and law enforcement for moderate to severe external bleeding control. VETIGEL®, launched in 2021, serves the veterinary market and has been used in over 65,000 procedures globally. The technology is composed of plant-derived polymers that adapt to diverse wound geometries, ensuring consistent performance. Cresilon's innovations have earned recognition including a Gold Stevie Award and Fast Company's #1 ranking in medical devices for 2026. The company pursues expanding applications in surgical hemostasis and continues distribution partnerships with major healthcare networks.

Flat Medical is a medical device company specializing in advanced solutions for epidural anesthesia and regional pain management. The flagship EpiFaith® Smart Syringe delivers real-time visual pressure sensing to support accurate epidural needle placement, significantly reducing procedural variability, wet tap complications, and postdural puncture headaches (PDPH). The company also offers the EpiFaith CV Syringe for safe central venous catheterization. Designed by clinicians and validated through clinical research, Flat Medical's products help standardize placement success across operators and are rapidly gaining adoption as a new standard of care in epidural procedures. The company partners with hospitals, academic institutions, and regional anesthesia specialists to advance patient safety and clinical confidence in pain management and anesthesia delivery.

Airway Innovations, founded in 2016, is a medical device manufacturer specializing in advanced airway management solutions for anesthesia and sedation procedures. The company's flagship product, the AERIS Airway™, is a first-of-its-kind oxygen delivery and end-tidal CO₂ monitoring device designed for I.V. sedation, TIVA (total intravenous anesthesia), and post-deep extubation applications. AERIS modernizes traditional oropharyngeal airways (OPAs) and nasopharyngeal airways (NPAs) by integrating oxygen delivery and capnography monitoring capabilities, enabling anesthesia providers to comply with American Society of Anesthesiologists (ASA) guidelines. The device improves patient safety during sedation procedures, streamlines airway management workflows, and reduces healthcare costs. Airway Innovations addresses the clinical need for enhanced respiratory monitoring and oxygen delivery in settings where traditional methods like nasal cannulas and face masks fall short. The company is headquartered in Grand Rapids, Michigan.

CardioQuip is a US-based manufacturer of perfusion equipment specializing in cooler-heater devices for open-heart surgery and cardiac procedures. Originally established as a refurbisher of perfusion devices, the company leveraged extensive feedback from surgeons, biomeds, and perfusionists to design and manufacture innovative temperature control solutions. CardioQuip's flagship MCH-1000 series—including the MCH-1000(i) and MCH-1000(m) models—delivers precise patient temperature management with intuitive touchscreen interfaces, simplified cleaning protocols, and enhanced safety features. The MCH-1000(i) provides best-in-class performance with a 36L insulated tank and 1600W heating capacity, while the compact MCH-1000(m) offers full-sized performance in a space-conscious footprint. The VivaCart™ (VC-1000) provides portable transport and integration with most perfusion pumps. All equipment is designed and manufactured in the USA. CardioQuip also provides comprehensive technical support, preventive maintenance programs, and regional distribution services across North America and internationally.

Belmont Medical Technologies is a medical device manufacturer specializing in fluid warming, fluid management, and patient temperature regulation solutions for critical care environments. The company develops precision-controlled devices designed for hospitals, surgical centers, emergency transport, military combat fields, and EMS settings. Belmont's portfolio addresses hypothermia prevention, intraoperative normothermia maintenance, and therapeutic temperature management. The Belmont® Rapid Infuser RI-2 delivers warmed blood and fluids at rates from 2.5 to 1000 ml/min with automatic air detection; buddy lite® provides portable, battery-powered warming for field and transport use; Allon® and CritiCool® systems maintain perioperative body temperature non-invasively using algorithm-driven heat pumps and disposable patient garments; and the Hyperthermia Pump™ performs intraperitoneal and thoracic hyperthermic lavage with electromagnetic induction heating. All disposables are aluminum-free and feature intuitive touchscreen interfaces. Belmont has earned significant U.S. military contracts for fluid resuscitation and temperature management.

ISO 13485:2016 certified, FDA-approved medical device manufacturer specializing in respiratory, anesthesia, emergency, and critical care components. Instrumentation Industries supplies a comprehensive range of ventilator circuit accessories including connectors, adapters, exhalation valves, tubing, and water traps. The company manufactures manual jet ventilators, endotracheal tube changers, MDI adapters, and pressure/vacuum gauges. Products also include airway management devices, oxygen delivery systems, breathing bags, and silicone rubber connectors—many featuring reusable, autoclavable designs. Founded in 1967 and based in Pittsburgh, PA, the company serves respiratory therapists, emergency medical services, and critical care facilities with high-precision, difficult-to-find medical components manufactured domestically.

CardioCommand Inc. is a leading medical technology innovator headquartered in Tampa, Florida, specializing in transesophageal (TAP) pacing and cardiac monitoring devices. Established in 1994, the company delivers minimally invasive cardiac solutions designed for clinicians in cardiology and anesthesia settings. CardioCommand's product portfolio includes transesophageal atrial pacing systems, esophageal catheters, electrode solutions, and noninvasive cardiac monitoring equipment. The company serves major academic medical centers, children's hospitals, and healthcare systems nationwide, supporting both diagnostic and therapeutic cardiac interventions including arrhythmia management, stress testing, and atrial cardioversion. Their TAP technology platform enables safe, easy-to-use cardiac assessment and management with minimal patient invasiveness.

Ontogen Medtech is a full-service medical device development and contract manufacturing partner based in Lisle, Illinois. Founded in 2021, the company specializes in end-to-end product realization for Class I, II, and III medical devices and in-vitro diagnostics across multiple therapeutic areas including orthopedics, cardiovascular, neurosurgery, women's health, pediatrics, and airway management. Services encompass strategic product design, engineering, prototyping, verification and validation testing, regulatory management (FDA compliance, 510(k) support), design history file documentation, and contract manufacturing from pilot builds to large-scale production. Ontogen operates a state-of-the-art facility with Class 7 cleanroom capabilities and sterilization coordination expertise. The team brings over 45 years of combined experience in sensor-driven smart devices, minimally invasive catheters, drug preparation and infusion systems, and class III implants. The company serves entrepreneurs, startups, and established medical device organizations, with a track record supporting clients through SBIR grants, pitch competitions, patent filings, and FDA clearances.

InnoVoyce develops advanced solid-state laser technologies for the prevention, diagnosis, and treatment of voice disorders and ENT procedures. The company manufactures the VYLO™ 455nm blue light surgical laser system, engineered for precision soft tissue surgery with up to 30 watts of power and multiple operational modes. InnoVoyce also produces FDA-cleared laser fibers (0.3mm, 0.4mm, 0.6mm diameters) and surgical accessories designed to enhance procedural precision and patient outcomes. Founded through collaboration with Harvard Medical and the Voice Health Institute, InnoVoyce addresses the clinical needs of millions with voice pathologies, offering versatile solutions for laryngeal procedures, voice health restoration, and broader ENT applications. The company maintains active participation in major otolaryngology and head-neck surgery conferences, with ongoing research and development in biomaterials and laser fiber innovation.

Larynnovation Inc. is a San Diego-based medical device company specializing in innovative airway management solutions. The company develops advanced endotracheal tube support systems designed to optimize airway ergonomics, prevent device-related injury, and enhance patient outcomes during intubation. Their flagship product, IntuClip (formerly EndoClip), is an evidence-based airway intervention validated through preclinical studies demonstrating significant pressure reduction in airways and throat tissues. The company focuses on addressing unmet clinical needs in anesthesia and critical care by delivering cost-effective, intuitive devices that reduce post-intubation laryngeal complications. Larynnovation collaborates with healthcare professionals and academic institutions, including participation in randomized controlled trials and presentations at major otolaryngology and anesthesiology conferences.

Securisyn Medical develops innovative airway management and securement devices designed to enhance airway safety, prevent unplanned extubation, and reduce associated clinical complications. The company's core focus is on endotracheal tube stabilization solutions for both adult and pediatric populations, including neonatal applications. Their flagship product, SolidAIRity® Flex, targets adult airway securement with applications across ICU, operating room, and field trauma environments. Securisyn's approach emphasizes patient safety, practitioner confidence, and healthcare cost reduction through evidence-based device design and clinical validation. The company is committed to sustainable, ethical business practices while advancing ventilator safety standards and airway management protocols across acute care settings.

Senzime is a medical technology company founded in 1999 and headquartered in Uppsala, Sweden, specializing in advanced patient monitoring and diagnostic systems for anesthesia and acute care. The company's flagship product, TetraGraph, is an electromyography (EMG)-based neuromuscular blockade monitoring system that provides quantitative train-of-four (TOF) monitoring to optimize intubation conditions, neuromuscular block management, and reversal dosing during surgical anesthesia. TetraGraph has been used to monitor over one million patients worldwide and is trusted by thousands of clinicians. The system delivers real-time, objective measurements of neuromuscular function, enabling safer anesthesia practices, improved patient outcomes, and significant operational efficiencies including documented reductions in anesthesia drug spending. Senzime operates globally through direct sales offices in the US, Sweden, and Germany, supported by an extensive network of distributors across Europe, Asia-Pacific, and North America. Listed on NASDAQ Stockholm (ticker: SEZI), Senzime is committed to advancing the standard of care in perioperative monitoring through evidence-based solutions and comprehensive clinical support.

SURU International PVT LTD is a medical device manufacturer and exporter based in Dahanu, Maharashtra, India. The company specializes in the design, manufacture, and distribution of a comprehensive range of medical disposable devices and supplies. With ISO 13485:2016 certification and US FDA approval, SURU serves hospitals, clinics, and healthcare facilities globally through B2B supply chains. The company manufactures critical products across multiple clinical specialties including airway management, biopsy systems, blood bank systems, cardiology devices, dialysis equipment, gastroenterology supplies, gynecological instruments, infusion and transfusion therapy systems, regional anesthesia kits, respiratory care equipment, surgical sutures and mesh, wound care products, and urology devices. SURU offers OEM services and maintains regulatory compliance with international standards. The company actively participates in major international medical trade shows including Arab Health, FIME, and MEDICA, indicating strong export presence and commitment to global market expansion.

MarketLab is a healthcare products distributor founded in 1994 that specializes in low-to-mid volume specialty items and hard-to-find solutions for healthcare professionals. The company serves clinical laboratories, anesthesia, operating rooms, radiology, MRI, ultrasound, home healthcare, pharmacy, and sterile processing departments across U.S. health systems, integrated delivery networks, and government agencies. Product offerings span phlebotomy supplies, patient positioning and comfort items, safety equipment, infection control and PPE dispensers (Bowman brand), medical carts and furniture (Insight brand), tube caps and racks, airway management, eye protection, and medical bags. MarketLab operates nine trusted brands and emphasizes quality, competitive pricing, and direct feedback from healthcare professionals to develop practical solutions that improve workflow and reduce procurement friction.

Through The Cords designs and manufactures next-generation airway management tools purpose-built for video laryngoscopes. The company's flagship product, the Runnels Steerable Introducer™, addresses critical gaps in difficult airway management by providing articulating tip control and intuitive depth control to improve first-pass intubation success rates and reduce complications. Founded by Dr. Sean Runnels, Through The Cords applies disruptive innovation principles to make advanced airway management accessible and affordable globally, with particular focus on low-resource settings. The company targets emergency medicine, anesthesia, critical care, and first-responder markets, addressing the fact that 55% of failed intubations in EDs and ICUs result from inability to direct the endotracheal tube into the trachea. Annual intubation complications cost the healthcare system over $5 billion and result in approximately 60,000 deaths, creating strong clinical and economic drivers for improved airway tools.

NeuroWave Systems Inc. is a medical device manufacturer specializing in advanced brain monitoring technologies for anesthesia, sedation, and critical care applications. Founded in 2007 as a spin-off from CleveMed, the company develops innovative EEG-based monitoring systems that provide real-time assessment of brain function and anesthetic effect. The flagship NeuroSENSE® Monitor delivers bilateral brain indices, enabling clinicians to detect asymmetries in brain function and optimize patient-specific drug delivery. The company's product portfolio includes the NeuroSENSE OEM Module for third-party integration and specialized electrodes for high-quality signal acquisition. NeuroWave targets operating rooms, ICUs, and anesthesia departments, emphasizing automation in anesthesia protocols to improve patient safety and reduce healthcare costs through precise, data-driven sedation management.

Stellmacher Instruments Inc. is a Florida-based surgical instrument manufacturer and B2B distributor founded in 2001, specializing in high-quality, precision-engineered specialty surgical instruments. The company provides a comprehensive range of reusable and single-use instruments across multiple surgical disciplines, including anesthesia (laryngoscopes, intubation stylets), ophthalmic (forceps, cannulas, speculums, surgical sets), plastic surgery (dissectors, liposuction cannulas, retractors), orthopedic (bone rongeurs, mallets, elevators), dental (extracting forceps, student kits), electrosurgical (cautery pencils, grounding pads, bipolar cables), general surgical (forceps, scissors), and laparoscopic instruments. The company also offers sterilization trays, student practice kits, and surgical sutures. Operating via an e-commerce platform with nationwide USA shipping, Stellmacher prioritizes maintaining rigorous industry standards, offering custom-made instruments, and delivering efficient solutions to surgical facilities, hospitals, and healthcare practitioners globally.

SYNERGY Medical is a comprehensive medical imaging, equipment, and supply distributor serving hospitals, health systems, ambulatory surgery centers, clinics, and government facilities across the United States and internationally. The company specializes in OR integration systems, surgical and diagnostic displays, surgical lighting solutions, medical video recording and imaging systems, and equipment booms. With a distribution network exceeding 50,000 products from nationally recognized manufacturers including Eizo, Barco, JVC, Sony, NDS Surgical Imaging, Bovie, AMICO, and Simeon Medical, SYNERGY partners closely with vendors to deliver high-quality solutions that reduce costs and improve operational efficiency. Core product categories include 4K surgical monitors, LED surgical lighting systems, diagnostic monitoring displays, video integration systems, surgical cameras, medical booms, suspension arms, electrosurgical equipment, and wireless imaging solutions. The company serves clinical engineering, radiology, purchasing, and supply chain decision-makers across institutional and government healthcare settings.

Epimed International, Inc. is a specialized medical device manufacturer founded in 1992, with facilities in Dallas, Texas and Johnstown, New York. The company designs, manufactures, and distributes high-precision needles, catheters, and related devices for interventional pain management and regional anesthesia procedures. Epimed's core focus is on acute and chronic pain treatment through minimally invasive techniques. The company's product portfolio includes Spring Guide Catheters, Racz® Catheters, radiofrequency ablation tools, cryoneuroablation systems, and specialty nerve block needles. Epimed also provides complementary services including medical training, physician education, healthcare practice consulting, and clinical education support. With ~106 employees and approximately $9.7M in annual revenue, the company emphasizes precision, safety, and risk reduction in interventional procedures, actively participating in industry conferences and workshops.

McMurray Medical manufactures the McMurray Enhanced Airway (MEA), an innovative distal pharyngeal airway device designed to improve patient safety, clinician satisfaction, and healthcare cost outcomes. The MEA represents a significant redesign of traditional oral airways, which have remained largely unchanged for nearly 100 years. The device features a longer, softer, smaller-diameter construction with a shock-absorbing bite block that shifts bite pressure to the molars, reducing postoperative discomfort and dental damage risk. It integrates with anesthesia circuits and bag-valve-mask systems for delivery of apneic or passive oxygenation during intubation. The MEA addresses critical gaps in airway management by providing effective airway maintenance, relieving difficult mask ventilation, enabling secure placement without lubricant or tongue depressor, and reducing upper airway obstruction. The device is compatible with endoscopic procedures and supplied in individual pouches for convenient clinical use and stocking.

NovaMedUSA, Inc. is a manufacturer and distributor of specialty medical products serving anesthesiology, cardiology, neonatology, and critical care markets. The company specializes in temperature monitoring solutions, including core body temperature probes, neonatal skin temperature sensors compatible with major incubator systems (GE/Ohmeda, Dräger, Atom Medical), and wireless temperature monitoring. Product lines include fiber optic laryngoscopes (PREMIER, standard, LED, and MRI-conditional variants) for intubation procedures, esophageal stethoscopes (LIFESOUND) for heart/breath sound monitoring, and conductive patient warming systems (KOALA for adults and KOALA Infant Warmer for neonates) designed to prevent perioperative hypothermia. NovaMedUSA emphasizes energy-efficient, eco-friendly technology and SCIP-INF-10 compliant products. The company operates customer support Monday–Friday, 8:30 am–8:30 pm EST, with dedicated channels for current customers, prospective buyers, and dealer partners.

Weihai Kaibo Medical Device Co., Ltd. is a Chinese medical device manufacturer founded in 2019, specializing in minimally invasive surgical instruments and endoscopic systems. Located in Weihai Medical Devices and Biopharmaceutical Industrial Park, the company is a national high-tech enterprise and member of the National Surgical Instruments Standardization Technical Committee. The company develops and manufactures innovative microinvasive surgical medical devices designed to work with endoscopic technology. Product portfolios span three major clinical areas: laparoscopic surgery, urological surgery, and gastrointestinal endoscopic diagnosis and treatment. The company holds 19 utility patent authorizations and participates in formulating national medical device standards. Recent product certifications include EU compliance certifications for disposable negative pressure drainage bags and suction connection tubing from German TÜV Rheinland.

SharpMed, LLC is a medical device development and commercialization partner based in Scottsdale, Arizona. The company specializes in bringing innovative medical device concepts from ideation through regulatory approval and commercial launch. SharpMed's core offering is comprehensive end-to-end support for medical device entrepreneurs and innovators, leveraging a multidisciplinary team with 150+ years of combined expertise in Class I and II device development. The company's service portfolio encompasses biomedical engineering, product design and prototyping, regulatory affairs, manufacturing guidance, clinical validation, legal affairs, M&A strategy, and go-to-market commercial planning. SharpMed's first commercial product is the Turbo® O₂ Cap, a Class I non-sterile airway accessory designed to deliver 100% oxygen directly to the glottic region during difficult or emergent intubations, helping prevent oxygen desaturation in paralyzed patients.

ANEclear is a patented medical device designed to accelerate the washout of inhaled volatile anesthetics from the brain at the end of surgery. The device uses the patient's own carbon dioxide to vasodilate cerebral vasculature and restore electrical signaling in neurons controlling wakefulness and breathing, enabling faster and safer anesthesia emergence. ANEclear is specifically indicated for elderly, obese, and pediatric patients at elevated risk for postoperative complications including delirium, postoperative cognitive dysfunction, airway obstruction, and nausea/vomiting. By rapidly reversing anesthetic effects in the brain, ANEclear reduces recovery time, lowers complications, and improves operating room and post-anesthesia care unit efficiency while reducing overall patient care costs.

Boca Dental Regenerative is a comprehensive dental supplier offering a broad portfolio of equipment, instruments, consumables, and biomaterials for general dentistry, oral surgery, and regenerative procedures. Product lines include dental handpieces and electric motors, PRF (Platelet-Rich Fibrin) centrifuges and collection systems, bone graft materials (mineralized and demineralized allografts, bovine anorganic bone, pericardium membranes), dental instruments (curettes, luxators, elevators, extraction forceps, retractors, needle holders, scissors, scalpel handles), CBCT/3D imaging and digital impression scanners, dental chairs and stools, surgical lighting, sterilization cassettes (wire mesh and solid series), sutures (resorbable and non-resorbable), implant systems and guides, infection control supplies (gloves, surgical masks 510(k), PPE), blood handling consumables (collection tubes, butterfly needles, tube holders), and disposable sterile drapes. The company represents multiple brands including BocaDental Supply, Atomica, Fussen, and Prexion. They also offer PRF educational courses and certification training at multiple US locations (Boca Raton, New York, San Diego, Denver, Honolulu, Las Vegas, Los Angeles). The business model combines wholesale distribution with direct-to-practitioner sales via their e-commerce platform.

Pacific Hospital Supply Co., Ltd. (PAHSCO) is a Taiwan-based medical device manufacturer specializing in single-use and reusable medical consumables and drainage systems for critical care, surgical, anesthesia, and respiratory therapy applications. The company manufactures closed suction systems, pleural drain systems (both dry-seal and water-seal variants), closed wound drainage systems (evacuator bulb type), urinary drainage bags, and OHMEDA-branded medical gas outlets. PAHSCO serves hospitals and healthcare facilities globally with products designed for critical care wards, general surgical applications, wound drainage management, respiratory therapy and anesthesia support, pediatric/neonatal care, and medical gas system infrastructure. The company emphasizes R&D capabilities and quality manufacturing standards. Products are marketed across multiple specialty applications including critical care support, general surgery, equipment protective covers, and respiratory/anesthesia management. The company is listed as a public entity with investor relations and ESG (environmental, social, governance) commitments. All products appear to comply with international medical device standards for use in hospital and clinical settings.

Somavac Medical Solutions manufactures the SOMAVAC® Sustained Vacuum System (SVS), an FDA-cleared negative pressure wound therapy device designed for post-operative drain management following large flap-forming plastic and general surgeries. The system represents a significant advancement over traditional bulb-drain technology, offering closed-system fluid removal that enables patients to return to normal activities faster—clinical data shows drain removal approximately 30% sooner than conventional methods. The SOMAVAC® SVS is a wearable, fully enclosed system that continuously removes fluids while holding tissue layers together, eliminating the need for manual fluid stripping and bulb manipulation. Key differentiators include discretion, comfort, cleanliness, and mobility compared to legacy drainage approaches. The company operates a 24/7 call center for patient support and maintains FDA regulatory clearance for its indication. Patient testimonials highlight reduced recovery time, ease of self-management, and improved quality of life during post-operative healing. The device is positioned for use in acute post-surgical settings across plastic surgery, breast reconstruction, and general surgery applications. Somavac serves healthcare providers, nursing staff, and patients, with marketing and educational resources targeting all stakeholder groups.

Sedation Systems LLC manufactures the NITROUSEAL® system, a complete, FDA-cleared nitrous oxide sedation platform designed for safe, self-administered patient analgesia in medical and dental settings. The system features a patented disposable full-face mask and breathing circuit with state-of-the-art all-digital flowmeter technology, enabling precise nitrous/oxygen dosage control (0–50% nitrous, up to 70% in select regions). The NITROUSEAL® system is the only complete nitrous analgesia platform with integrated waste gas scavenging via the Miniscav® FDA-cleared gas evacuation system, minimizing occupational exposure to exhaled nitrous oxide and reducing room contamination—a key safety requirement endorsed by CDC, NIOSH, and OSHA. This opioid-free, rapid-onset sedation solution allows patients to drive themselves home post-procedure. Indicated for pediatric, obstetric, dental, urological, and facial/body procedural applications across hospitals and medical offices nationwide. The company provides comprehensive on-site training, clinical support, and uninterrupted service plans.

Oneg HaKarmel Medical Devices Ltd (OHK MED) is an Israeli medical device manufacturer founded in 1999, specializing in innovative solutions for critical care medicine, hemorrhagic shock management, and orthopedic/vascular surgical applications. The company develops and manufactures advanced physiological devices focused on blood loss management in limb surgery, severe hemorrhagic shock (SHS) resuscitation, and cardiac arrest emergency response. OHK MED's product platform combines strong regulatory compliance with strategic partnerships to address unmet clinical needs in emergency medicine and perioperative care.

Founded in 1991, Adroit Medical Systems is an FDA-registered medical device manufacturer specializing in active and passive patient warming systems, localized hot and cold therapy equipment, and surgical drapes and instrument covers. The company manufactures Class I and Class II medical devices for clinical and veterinary applications, with products including hypo-hyperthermia water therapy systems (HTP-1500), forced-air convective warming units (Soft-Air OR-110), reflective heat blankets (ThermalX), cold therapy pads and wraps, and portable cooling systems (Mobile Ice). Adroit serves hospitals nationwide and veterinary clinics through major medical distributors including Medline, Cardinal Health, and Owens & Minor. ISO 13485:2003 and ISO 9001:2008 certified, the company manufactures all products in-house at its Tennessee facility and provides contract manufacturing services, equipment repair, and calibration support.

Pramand LLC develops implantable medical devices using proprietary hydrogel technology to address unmet clinical needs across surgical interventions. The company focuses on creating hydrogel-based solutions that improve patient outcomes while reducing therapy costs. Pramand's portfolio includes three primary product lines: a hydrogel implant for minimizing intrauterine adhesions (IUAs) in gynecological procedures, a dural sealant for watertight dural closure following craniotomy in neurosurgery, and a hemostatic sealant patch for controlling moderate surgical bleeding. The company operates through a business model of self-funding preclinical development with financial partners supporting clinical development and commercialization. Pramand's leadership team has successfully launched over ten hydrogel-based medical device companies that have generated over $4 billion in value and exits, collectively serving over 5 million patients worldwide. The company's proprietary hydrogel platform positions it as a specialized developer in the implantable device sector, with particular expertise in surgical sealants and hemostatic applications.

Solo Pace Inc manufactures temporary pacing technology and systems engineered specifically for transcatheter heart valve (THV) procedures. The company specializes in precision pacing solutions that provide confident control during valve deployment while reducing patient risk. Product lines include the SoloPace CONTROL™ System, an innovative pacing platform designed to reduce pacing risk and improve procedural efficiency during THV interventions, and the SoloPace FUSION™ System, a fully integrated sterile kit that combines temporary intracardiac pacing with streamlined THV device delivery. These solutions address a critical clinical need in structural heart interventions where reliable, precise temporary pacing is essential during transcatheter aortic valve replacement (TAVR) and other valve procedures. The company serves interventional cardiologists, structural heart specialists, and cardiac catheterization laboratories. Solo Pace's products are designed for hospital-based cardiac catheterization and hybrid operating room environments. Specific regulatory certifications and manufacturing details are not provided on the available website content.

MACB, LLC manufactures the MACB® Introducer, a surgeon-placed adductor canal block device designed for intraoperative regional analgesia in total knee arthroplasty (TKA) procedures. The device enables surgeons to deliver non-opioid pain management directly during surgery, providing 4–5 days of pain relief and facilitating same-day discharge for outpatient TKA in ambulatory surgery centers. The MACB® Introducer offers both catheter-based therapy and non-catheter options using liposomal bupivacaine, eliminating the need for additional anesthesia procedures and reducing opioid-related complications and hospital stays. Developed by Dr. Daniel Matthews, MD, FAAOS, an orthopedic surgeon with 30+ years of experience, the device has been extensively validated in clinical practice with over 2,100 placements and peer-reviewed publications demonstrating superior nerve coverage compared to ultrasound-guided blocks alone. The company distributes catheter-based therapy products exclusively through Avanos Medical Technologies in the United States. MACB targets orthopedic surgeons and surgical centers seeking to implement opioid-free pain management protocols for knee arthroplasty.

National Medical Products, Inc. (NMP) manufactures the J-Tip Needle-Free Injection System, an FDA-cleared medical device that delivers local anesthesia and medications using CO2-propelled jet injection technology. The single-use, sterile device administers buffered or preservative-free lidocaine subcutaneously without a needle, providing anesthetic effect within 1–2 minutes for IV insertion, blood draws, and routine needle procedures. Designed to minimize patient discomfort and address needle phobia across all ages, the J-Tip is used in emergency departments, pediatric care, and anesthesiology settings. Founded in 1989 and based in Irvine, California, NMP manufactures all products in the USA and serves over 400 partner hospitals, helping more than 5 million patients experience virtually pain-free procedures while enhancing patient satisfaction and operational efficiency.

OSYPKA is a multinational medical device manufacturer with over 45 years of experience specializing in interventional cardiology and pediatric cardiology solutions. The company develops and manufactures active implants and catheters for cardiac applications, including pacemaker electrodes and radiofrequency ablation systems. OSYPKA operates as both a branded product manufacturer and a contract development and manufacturing organization (CDMO) serving global medical device partners with turnkey solutions for implantable devices and catheters. The company pioneered the first fracture-resistant implantable pacemaker electrode and has developed innovative technologies in cardiac intervention and neurostimulation. OSYPKA maintains manufacturing and quality capabilities across three main locations: Germany (headquarters in Rheinfelden), the USA (Longmont, Colorado), and the Czech Republic (Odry). The organization holds ISO 13485:2016 certification, EU Quality Management System certification under MDR (Medical Device Regulation), and Czech Quality Management System certification. The company serves interventional cardiologists, hospital systems, and medical device OEMs worldwide with both proprietary product lines and custom manufacturing solutions.

Advanced Meditech International Inc., based in New York City since 1992, is a B2B supplier of surgical equipment and instruments designed to enhance safety, simplicity, and cost-effectiveness in medical practice. The company specializes in no-needle jet injection anesthesia devices (MadaJet systems), electrosurgery generators, thermal cautery equipment, ligating clips and appliers, sterilization and ultrasonic cleaning solutions, and PPE surgical masks. The MadaJet platform is available in multiple configurations for dental, general medical, urology, podiatry, and vasectomy applications, enabling local anesthesia delivery without needle injection. The company also distributes complementary surgical equipment from established manufacturers including Teleflex, Bovie, and Mada Medical. All products are rigorously tested and fully inspected before certification and shipment. Customer service is available 24/7 by phone, fax, and email.

Johnson & Johnson is a multinational healthcare company founded in 1886 in New Brunswick, New Jersey. It specializes in pharmaceuticals, medical devices, and consumer health products. The company operates primarily through two business divisions: Innovative Medicine and MedTech. Innovative Medicine develops therapies across oncology, immunology, neuroscience, and cardiopulmonary disease areas. MedTech innovates at the intersection of biology and technology, focusing on minimally invasive and personalized treatments in cardiovascular, orthopedic, surgical, and vision care. J&J's portfolio includes surgical supplies, antiseptic sutures, diagnostic devices, and therapeutic equipment. With over 260 subsidiaries and 130,000+ employees globally, J&J is one of the largest and most diversified healthcare organizations, committed to addressing complex health challenges through rigorous science and innovation.

Artivion is a specialized cardiovascular medical device company focused exclusively on aortic and cardiac surgery solutions. The company manufactures and markets a comprehensive portfolio of devices for treating aortic diseases, aortic dissections, and cardiac valve disorders. Product lines include mechanical and biological heart valves (ON-X Aortic and Mitral Valves, CRYOVALVE allografts), aortic arch solutions (AMDS Hybrid Prosthesis, E-VITA OPEN NEO, NEXUS stent graft systems), thoracoabdominal and abdominal aortic stent grafts (E-TEGRA, E-LIAC, E-NSIDE TAAA), peripheral aortic devices, and ancillary surgical solutions including BIOGLUE surgical adhesive and decellularized pericardium (PHOTOFIX). Artivion recently acquired Ascyrus Medical in 2020, expanding its aortic arch offerings. The AMDS Hybrid Prosthesis, developed for acute DeBakey Type I aortic dissections, received FDA Humanitarian Device Exemption (HDE) in December 2024 and is supported by the PERSEVERE pivotal clinical trial. Products are regulated through FDA 510(k) clearances and PMA pathways, with multiple investigational device exemptions (IDEs) active. The company collaborates with cardiac and vascular surgeons worldwide and supports clinical evidence generation through real-world post-market studies and pivotal trials. Artivion serves hospitals, surgical centers, and cardiac/vascular surgery programs globally, with particular emphasis on advanced aortic interventions and valve replacement technologies.

HK Surgical is a leader in the development, distribution, and marketing of liposuction and fat harvesting/grafting surgical supplies, founded in 1998 by Dr. Jeffrey Klein. The company specializes in equipment and supplies for tumescent local anesthesia procedures, including the proprietary Klein Infiltration Pump (available in multiple models: KIP-II+, KTDD). HK Surgical offers a comprehensive product portfolio encompassing infiltration and aspiration pumps, surgical cannulas (reusable and single-use), fat collection and transfer systems, infiltration tubing sets, positioning pillows, super-absorbent surgical pads, OR table sheets, compression garments, and catheter sets. The company serves plastic surgeons, physicians, nurses, and patients, emphasizing superior quality, reliability, and value. Products are FDA-approved and designed for liposuction, body contouring, varicose vein ablation, and facial procedures. HK Surgical provides same-day shipping on orders placed by 1 PM PST and offers live customer support.

Med Surgical Instruments Inc. is a global provider of medical devices and surgical instruments serving healthcare providers in critical care, general surgery, regional anesthesia, urology, respiratory care, and cardiac care applications. The company manufactures and supplies a comprehensive range of surgical instrument sets and specialty medical devices for hospitals, surgical centers, and medical device manufacturers worldwide. Product lines include sterilization containers, general surgical instruments, orthopedic surgical sets, electrosurgical instruments, reconstructive and plastic surgery instruments, dental instruments, and veterinary surgery instruments. The company also offers custom graphic containers and Med-Cut scissors. Med Surgical operates an OEM division providing products and services to device manufacturers, and maintains repair and servicing capabilities including instrument reconditioning, warranty services, and additional technical support. The company serves markets across the USA, Europe, and Asia with availability varying by region. Quality control and instrument care protocols are documented, and the company is PayPal-verified for transactions.

Resolution Medical is a medical device development and manufacturing partner specializing in complex catheter delivery systems, active implantable devices, and component manufacturing. The company serves structural heart, cardiology, vascular, heart failure (VAD), neuromodulation, electrophysiology, and additional specialty markets including ENT, neurology, urology, oncology, endoscopy, and robotics. Core capabilities span the full product lifecycle: concept and design development, BioSimulation and testing with cardiovascular visualization in pressurized heart models, New Product Introduction (NPI) with design-for-manufacturing optimization, and end-to-end manufacturing from prototyping through commercial production. Resolution Medical operates specialized clean rooms, sterile packaging, labeling, and distribution infrastructure. In structural heart, the company develops implants and catheter delivery systems for mitral, tricuspid, aortic, and pulmonary valve interventions, as well as shunts, stents, closure devices, and embolic protection. Cardiology and vascular expertise includes complex delivery platforms, imaging and sensing catheter systems for peripheral, neurovascular, and cardiovascular applications, DVT/PE management, drug delivery, and flow management. Heart failure capabilities encompass VAD pump development, drivelines, and deployment systems. Neuromodulation focus includes Class III active implantables: implantable pulse generators (IPGs), leads, headers, adapters, and subassemblies for spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, and peripheral nerve modulation. Electrophysiology specialization covers diagnostic mapping and energy delivery catheters with modalities including pulsed field ablation (PFA), RF energy, cryotherapy, and vapor therapy. The company maintains a quality management system per ISO 13485:2016 and operates under FDA guidelines. Resolution Medical was recently acquired by Resonetics (2025) and operates with 100+ engineers backed by 1,000+ combined years of experience.

Spectrum Medical Inc is a global medical technology company specializing in cardiac perfusion and intensive care solutions for operating rooms and ICUs. Headquartered in Gloucester, United Kingdom, with significant US operations in Fort Mill, South Carolina, the company serves hospitals across more than 60 countries. The company develops and manufactures the Quantum Perfusion Technologies product line, including cardioplegia delivery systems and perfusion management solutions designed to improve clinical outcomes in cardiac surgery. Their Quantum Micro-Cardioplegia Delivery System received FDA 510(k) clearance. Spectrum Medical also offers Quantum Informatics-24, a health IT solution for cardiac and ICU environments. The company markets its solutions to cardiac surgeons, perfusionists, and ICU teams, combining hardware platforms with clinical decision support and data management capabilities. Products target high-acuity surgical and intensive care settings where cardiopulmonary perfusion and monitoring are critical. The company maintains regional sales and support offices in Europe, Italy, Australia/New Zealand, and the Middle East, with dedicated customer support and technical education resources available through their IFU (Instructions for Use) platform.

Jiangsu Yongle Medical Technology Co., Ltd. is a professional manufacturer of anesthetic laryngoscopes and endoscopic visualization equipment with 19 years of production experience. Founded in 2014, the company specializes in video laryngoscopy systems, flexible fiber optic laryngoscopes, anesthesia pharyngeal laryngoscopes, and related airway management instruments. The company produces the SMT series medical visualization laryngoscopes used in anesthesia departments, emergency care, ICU, and pediatric settings for intubation, emergency ventilation, and difficult airway management. Products feature cold light source illumination (6000 Lux), full waterproof design (IPX7 rating), photo/video capabilities, and compatibility with both reusable and disposable blades. The company holds CE0197, FDA registration, and ISO 13485 certification, with products distributed nationally and internationally across America, Europe, South Africa, and Southeast Asia.

Mevion Medical Systems is a radiation therapy company specializing in compact proton therapy systems for cancer treatment. Founded in 2004 and based in Littleton, Massachusetts, Mevion has raised $528.5 million in funding and maintains international offices in the United Kingdom and Japan. The company's flagship MEVION S250 Series comprises the MEVION S250 Proton Therapy System, MEVION S250i with advanced pencil beam scanning capabilities, and MEVION S250-FIT, designed for integration into existing radiation oncology departments. Mevion's systems are recognized for their compact design, which significantly reduces footprint, complexity, and capital/operating costs compared to conventional proton therapy equipment. The systems deliver 97–98% uptime and have achieved FDA clearance and CE marking. More NCI-Designated Cancer Centers select Mevion than any competing proton therapy vendor, reflecting strong clinical adoption and market leadership in particle therapy.

NeuroOne Medical Technologies develops minimally invasive diagnostic and therapeutic neurosurgical devices based on proprietary thin-film electrode technology. The company's primary platform enables high-definition neuronal recording and ablation for functional neurosurgery, with an initial focus on epilepsy and trigeminal neuralgia treatment. Core products include the OneRF® Radiofrequency Ablation System (FDA-cleared K231675 for functional neurosurgical procedures; K251243 for trigeminal nerve ablation), which uniquely performs both diagnostic mapping and therapeutic ablation using the same stereotactic electroencephalography (sEEG) electrode. The Evo® sEEG System (FDA-cleared K222404) provides temporary subsurface brain recording, monitoring, and stimulation, while the Evo® Cortical Electrodes (FDA-cleared K192764) offer surface brain recording with reduced immunological response and improved cable management. NeuroOne's flexible thin-film electrode platform is designed to provide higher-resolution neural signal acquisition compared to conventional rigid electrodes, potentially reducing infection risk and procedure complexity. The company is developing a comprehensive portfolio for neurological applications beyond epilepsy, working with leading neurosurgical centers including Mayo Clinic. All devices are subject to federal restriction to sale by or on the order of a physician.

Life Recovery Systems manufactures the ThermoSuit®, a non-invasive rapid patient cooling system for therapeutic hypothermia induction in emergency and operating room settings. The ThermoSuit achieves target body temperature of 33°C in approximately 30 minutes using rapid thin liquid convection technology—faster than traditional cooling blankets and gel pads. The system is designed for acute care applications including ischemic stroke, cardiac arrest, and other emergency conditions where controlled therapeutic hypothermia may improve patient outcomes. The company has published peer-reviewed clinical data in Frontiers of Neurology (2025) demonstrating safety and feasibility in acute ischemic stroke patients under an FDA Investigational Device Exemption. Life Recovery Systems is actively advancing clinical evidence through randomized controlled trials in partnership with the FDA. The ThermoSuit represents a significant advancement in non-invasive temperature management technology for critical care environments, addressing the clinical need for rapid and precise patient cooling in time-sensitive emergency procedures.

3T Medical Systems, Inc. (founded 1998) is a US-based medical device distributor and manufacturer specializing in surgical support equipment and clinical consumables. The company serves anesthesiologists, operating room nurses, sterile processing staff, infection prevention specialists, and surgeons performing specialized surgical procedures. 3T Medical operates a large distribution facility in the Midwest and a sales office in the Mid-Atlantic region, serving both domestic and international healthcare markets. The company's primary product lines include blood management systems (CONSTAVAC™ CBCII System for intraoperative blood reinfusion), anesthesia and laryngoscopy equipment, regenerative medicine products, and precision temperature management systems (Altrix, acquired from Stryker in 2025). 3T Medical also acquired Enterix, Inc. in 2022, expanding its portfolio in regenerative medicine and wound care solutions. 3T Medical holds ISO 13485:2016 certification, demonstrating compliance with international medical device quality management standards. The company focuses on reducing healthcare costs while improving patient outcomes through specialized equipment designed for complex surgical environments and perioperative care. Products are distributed to hospitals, surgical centers, and clinical institutions requiring blood management, temperature control, and anesthesia support capabilities.

Kairos Biosciences is a Salt Lake City, Utah–based regenerative medicine and surgical wound care company focused on enhancing acute surgical recovery. The company develops proprietary collagen and antimicrobial dressing technologies for high-risk surgical and wound environments. Primary product portfolio includes NuForra, a Type I collagen matrix powder featuring AngioReef™ technology with an 80–120 µm pore structure designed to support vascularization in complex surgical wounds, and PurForm AM, a silicone-backed antimicrobial foam dressing containing PHMB (Polyhexamethylene Biguanide) for post-operative wound management. Kairos targets community hospitals, long-term acute care hospitals (LTACHs), VA/DoD facilities, and specialized wound care centers. The company is DOBE-certified (Disabled Owned Business Enterprise), providing procurement advantages for distributor partners. Kairos emphasizes rapid innovation, proprietary formulation science, and patient-first product development with a lean organizational structure.

Verathon Inc. is a global medical device manufacturer specializing in airway management and bladder volume measurement solutions. Founded in 1984 and headquartered in Bothell, Washington, the company serves over 80 nations with a workforce of 360+ employees. As a subsidiary of Roper Technologies, Verathon is recognized for innovation in critical care and emergency medicine. The company's flagship GlideScope® video laryngoscope platform provides hyperangulated video-assisted intubation across single-use, reusable, and handheld configurations, addressing anesthesia, critical care, EMS, and pediatric airway management. The BladderScan® product line delivers noninvasive portable ultrasound systems for accurate post-void residual measurement and urinary retention management. BFlex® single-use bronchoscopes complement the total airway solution portfolio. Verathon emphasizes clinical evidence, sustainability (including bio-based plastic initiatives), and strong customer partnerships to enhance patient outcomes.

Merlyn Medical is a family-owned distributor of premium medical devices founded in 1998, specializing in sterile single-use disposables and respiratory/airway management products. The company manufactures advanced endotracheal tubes, laryngeal masks, and post-operative support devices in FDA-, ISO-, and CE-compliant sterile environments. Core product lines include EndoTube™ (high-volume, low-pressure cuff endotracheal tubes), EndoMask™ (silicone laryngeal masks with rapid insertion design), and EndoFlex™ (flexible endotracheal tubes with innovative distal tips). Merlyn Medical serves operating rooms, endoscopy suites, surgery centers, and hospitals, with particular strength in anesthesia and airway management. The company emphasizes product reliability, consistent quality control, competitive pricing, and responsive customer service. Manufacturing meets rigorous medical-grade material standards and regulatory requirements. Distribution includes global reach with a history of patented innovations in airway management. Target markets include CRNAs, anesthesiologists, surgical nurses, and hospital procurement teams seeking cost-effective, dependable airway supplies backed by exceptional customer support.

Covenant Healthcare Equipment and Consulting delivers cutting-edge surgical technologies designed to optimize operating room workflows, enhance surgical precision, and improve patient outcomes. The company specializes in advanced positioning systems, surgical smoke management, and anesthesia recovery solutions. Their core product portfolio includes TrenGuard (precision patient positioning system), Alesi Ultravision 2 (surgical smoke elimination and visualization), and ANEclear (anesthesia emergence management). These solutions address critical OR pain points: patient safety during positioning, surgeon visibility and occupational health during procedures, and faster, clearer patient emergence from anesthesia. Covenant positions itself as a provider of disruptive, technology-driven solutions that help healthcare systems build modern, efficient operating rooms. The company targets surgical facilities seeking to improve efficiency, reduce procedural complications, and advance clinical outcomes. While specific regulatory certifications are not detailed on the homepage, the focus on surgical precision, smoke management compliance, and anesthesia delivery suggests alignment with FDA and international standards for OR equipment. Covenant emphasizes consulting alongside equipment sales, indicating they provide implementation support and workflow optimization services.

Caretaker Medical manufactures VitalStream ART, a dual-modality continuous hemodynamic monitoring platform for ICU, operating room, and high-acuity care settings. The device delivers beat-by-beat hemodynamic data through both invasive arterial line connectivity and non-invasive wearable sensors, enabling clinicians to monitor patients from pre-operative assessment through discharge. VitalStream operates as a unified platform compatible with standard arterial lines (no proprietary transducers required) and integrates with GE Carescape and Philips Intellivue monitors. The wearable sensor provides up to 10 days of continuous monitoring without cabling, supporting patient mobility across care phases. Clinical validation includes 20 peer-reviewed studies documenting accuracy in surgical, ICU, and critical care populations. The company reports deployment in 150+ clinical customers across 20+ hospitals. VitalStream is FDA-cleared and CE-marked. Key clinical benefits include early detection of hemodynamic decompensation (cardiac output decline, missed hypotensive events), reduced acute kidney injury and myocardial injury post-surgery, and cost savings up to $300k annually per ICU room versus competing invasive systems. Operational setup requires under 90 seconds with no complex configuration.

enableCV, LLC is an independent cardiac surgery device company focused on advancing minimally invasive and open-heart surgical procedures. The company develops innovative medical devices designed to provide continuous blood flow during cardiopulmonary bypass and enable next-generation cardiac surgery techniques. EnableCV's product portfolio includes the IntraClude intra-aortic occlusion device for minimally invasive cardiac procedures, the ProPlege peripheral retrograde cardioplegia device for coronary sinus occlusion and cardioplegia delivery, the QuickDraw Plus femoral venous cannula for blood drainage during bypass, and arterial cannulae (OptiSite and EZ Glide) for short-term perfusion. The company leverages deep expertise developed through its heritage with Edwards Lifesciences and collaborates with a preeminent medical advisory board to expand its portfolio. All devices are FDA-regulated and restricted to sale by or on the order of a physician. EnableCV serves cardiac surgeons and cardiothoracic surgical centers requiring specialized bypass and cardioplegia management solutions.